Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Topical treatment of melanoma skin metastases with Imiquimod: a review
Andrea Sisti, Giovanni Sisti, Carlo M. Oranges
Dermatology Online Journal (2015) Vol. 21, Iss. 2
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Melanoma treatment: from conventional to nanotechnology
Harshita Mishra, Pawan Kumar Mishra, Adam Ekielski, et al.
Journal of Cancer Research and Clinical Oncology (2018) Vol. 144, Iss. 12, pp. 2283-2302
Closed Access | Times Cited: 154
Xanthan gum-based hydrogel containing nanocapsules for cutaneous diphenyl diselenide delivery in melanoma therapy
Luana Mota Ferreira, Marcel Henrique Marcondes Sari, Juliana H. Azambuja, et al.
Investigational New Drugs (2019) Vol. 38, Iss. 3, pp. 662-674
Closed Access | Times Cited: 59
Melanoma: An update on systemic therapies
Lauren Skudalski, Reid A. Waldman, Philip Kerr, et al.
Journal of the American Academy of Dermatology (2021) Vol. 86, Iss. 3, pp. 515-524
Closed Access | Times Cited: 48
The Diagnosis and Management of Cutaneous Metastases from Melanoma
Cosimo Di Raimondo, Flavia Lozzi, Pier Paolo Di Domenico, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14535-14535
Open Access | Times Cited: 14
Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer
Emilio Garcia‐Mouronte, Emilio Berná-Rico, Belén de Nicolás-Ruanes, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10835-10835
Open Access | Times Cited: 12
Intralesional treatment of metastatic melanoma: a review of therapeutic options
Benjamin Weide, Dario Neri, Giuliano Elia
Cancer Immunology Immunotherapy (2017) Vol. 66, Iss. 5, pp. 647-656
Open Access | Times Cited: 37
Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial
H.E. Teulings, Esther P.M. Tjin, Karina Willemsen, et al.
OncoImmunology (2018) Vol. 7, Iss. 4
Open Access | Times Cited: 36
The role of topical imiquimod in melanoma cutaneous metastases: A critical review of the literature
Federica Scarfì, Annalisa Patrizi, Giulia Veronesi, et al.
Dermatologic Therapy (2020) Vol. 33, Iss. 6
Open Access | Times Cited: 29
S3‐Leitlinie Diagnostik, Therapie und Nachsorge des Melanoms – Update 2015/2016, Kurzversion 2.0
Thomas Eigentler, Corinna Mühlenbein, Markus Follmann, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2017) Vol. 15, Iss. 6
Closed Access | Times Cited: 29
Current and emerging treatment options for metastatic melanoma: a focused review
Khoa A. Nguyen, Emma Hignett, Amor Khachemoune
Dermatology Online Journal (2020) Vol. 26, Iss. 7
Open Access | Times Cited: 26
Management of in‐transit melanoma metastases: a review
Emilia Nan Tie, Michael A. Henderson, David Gyorki
ANZ Journal of Surgery (2018) Vol. 89, Iss. 6, pp. 647-652
Open Access | Times Cited: 25
The role of immunotherapy and molecular‑targeted therapy in the treatment of melanoma (Review)
Paulina Stachyra‐Strawa, Marzanna Ciesielka, Michał Janiszewski, et al.
Oncology Reports (2021) Vol. 46, Iss. 2
Open Access | Times Cited: 17
Nanotechnology Addressing Cutaneous Melanoma: The Italian Landscape
Luigi Battaglia, Anna Scomparin, Chiara Dianzani, et al.
Pharmaceutics (2021) Vol. 13, Iss. 10, pp. 1617-1617
Open Access | Times Cited: 13
Tlr7 Agonist in Combination With Salmonella as an Effective Antimelanoma Immunotherapy
Magdalena Vola, Amy Mónaco, Thais Bascuas, et al.
Immunotherapy (2018) Vol. 10, Iss. 8, pp. 665-679
Closed Access | Times Cited: 15
Managing in-transit melanoma metastases in the new era of effective systemic therapies for melanoma
Rebecca L. Read, John F. Thompson
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 12, pp. 1107-1119
Closed Access | Times Cited: 15
Laponite® gel formulation containing simvastatin for melanoma treatment
Natália Suterio, Giovana Carolina Bazzo, Gabriela Schneider Rauber, et al.
Applied Clay Science (2022) Vol. 228, pp. 106651-106651
Closed Access | Times Cited: 7
Management of local or regional non‐nodal disease
Jennifer M. Racz, Matthew S. Block, Christian L. Baum, et al.
Journal of Surgical Oncology (2018) Vol. 119, Iss. 2, pp. 187-199
Closed Access | Times Cited: 9
Immunobiological efficacy and immunotoxicity of novel synthetically prepared fluoroquinolone ethyl 6-fluoro-8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate
Soňa Jantová, Ema Paulovičová, Lucia Paulovičová, et al.
Immunobiology (2017) Vol. 223, Iss. 1, pp. 81-93
Closed Access | Times Cited: 8
Acral lentiginous melanoma: A retrospective study
Ugo Redi, G Marruzzo, Stefano Lovero, et al.
Journal of Cosmetic Dermatology (2020) Vol. 20, Iss. 6, pp. 1813-1820
Open Access | Times Cited: 7
Soluble Factors and Receptors Involved in Skin Innate Immunity—What Do We Know So Far?
Lucian G. Scurtu, Olga Simionescu
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1795-1795
Open Access | Times Cited: 7
Topical and Intralesional Therapies for in-Transitmelanoma
Michael A. Henderson
Melanoma Management (2019) Vol. 6, Iss. 3
Open Access | Times Cited: 6
Melanoma in situ mimicking a Lichen planus-like keratosis.
Andrea Sisti, Amgiad Fallaha, Juri Tassinari, et al.
PubMed (2018) Vol. 88, Iss. 4, pp. 496-498
Closed Access | Times Cited: 5
Making decisions on resectability and injectability status of lesions in the management of advanced melanoma in Germany, France and the UK
Leah Fink, Justyna Amelio, Mark Harries, et al.
European Journal of Dermatology (2016) Vol. 26, Iss. 5, pp. 477-486
Closed Access | Times Cited: 3
Local Melanoma Recurrence, Satellitosis, and In-transit Metastasis: Incidence, Outcomes, and Selection of Treatment Options
John F. Thompson, Nicola Mozzillo, Merrick I. Ross
Springer eBooks (2020), pp. 867-894
Closed Access | Times Cited: 4
Management of In-Transit Metastases
Marcello Moro Queiroz, Eduardo Bertolli, Francisco Aparecido Belfort, et al.
Current Oncology Reports (2022) Vol. 24, Iss. 5, pp. 573-583
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top